She has a strong track record advising corporate, academic, and startup clients, helping them navigate complex IP considerations and maximise the commercial potential of their technology. She enjoys guiding early stage-ventures build IP strategies that are aligned with their business goals and position them for growth in both domestic and international markets.

Prior to joining DCC, Lyn completed a PhD in molecular genomics and cell biology at the University of Melbourne, followed by postdoctoral research at Monash University focused on stem cell genomic integrity and molecular drivers of ALT cancers. Her deep scientific expertise underpins her commercially focused approach to IP, making her a valuable partner to founders and investors operating at the cutting edge of biotech.